Clinical Skills Workshop | Neurostimulation in Epilepsy

Tuesday, December 8, 2026 at 8:30 AM to 11:30 AM · 3 hr. (America/Denver)
Skills Workshop

Information

This workshop has an additional fee, pre-registration is required. Seats are limited.

Neurostimulation is an FDA-approved treatment for drug-resistant epilepsy. Indications, efficacy, adverse effects, and programming vary by device. Additionally, programming of these approved devices can be complex and requires training and practice. Three stimulation devices are approved for these patients: the vagal nerve stimulator (VNS), the responsive neurostimulator (RNS), and the deep brain stimulator (DBS). This session discusses neurostimulation in drug-resistant epilepsy and provides a hands-on experience for interrogating and programming the three FDA-approved neurostimulation devices.

This workshop discusses the trials and post-marketing experience that established the tolerability and efficacy of these devices and instructs on how to use them effectively. Participants gain hands-on experience for interrogating and programming each of these devices.
Learning Objective 1
Describe indications, efficacy, and common adverse effects of vagal nerve stimulation, responsive neurostimulation, and deep brain stimulation
Learning Objective 2
Identify patients for whom a neurostimulation device is appropriate
Learning Objective 3
Demonstrate the ability to perform basic programming on each of the three neurostimulation devices
Target Audience
CliniciansFellows/TraineesAdvanced Practice Providers (APPs)
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalFirst-time AttendeesYoung Professionals
Session ID
CSWNEUROSTIM26
Presentation Id
3515287
Event ID
24056
Session Type
Session